MedTech Freedom to Operate: FTO Search and Analysis Basics for Startups

2026-09-12 · Caduvo Team

A freedom-to-operate analysis tells a medtech startup whether it can bring a device to market without infringing third-party patents. Learn FTO basics: what a search covers, when to run one, typical costs, and practical design-around strategies.

Late one Friday, a MedTech founder gets an email from a competitor’s law firm. The subject line: “Notice of Patent Infringement.” The product just launched. The founders never commissioned a freedom-to-operate analysis. They assumed that having their own patent meant they were in the clear. That’s a common misconception—and it can cost millions.

A freedom-to-operate (FTO) analysis tells you whether your device can be made, used, or sold without infringing third-party patents. It does not ask whether your innovation is patentable. For a medtech startup, the question shifts from “can we get a patent?” to “can we actually bring this product to market?”

FTO vs. Patentability: Two Different Questions

Patentability asks if your invention is new, useful, and non-obvious enough to earn you a patent. You might have a strong patent on a novel part of your device. But that doesn’t stop someone else from holding an earlier, broader patent that covers the whole product.

Example: a startup develops a smart inhaler with a new dose-counting mechanism. The dose counter is patentable and the company files a patent application. Meanwhile, a separate company holds a patent on a specific drug-canister interface used in many inhalers. If the startup’s product uses that interface—even if the dose counter is its own innovation—it may infringe. The startup’s own patent gives it no defense.

This is why freedom-to-operate analysis treats the product as a whole, not just the novel component. Patentability is an offensive IP move; FTO is defensive. Both matter, but they answer different questions.

What a Freedom-to-Operate Search Actually Examines

A freedom-to-operate search doesn’t skim patent titles or abstracts. It digs into the allowed claims of in-force U.S. patents and published patent applications. Claims define the legal boundary of what the patent owner can exclude. If your device—exactly as it will be sold—falls within even one claim, you have a problem.

The search maps each claim element against your device’s specifications, material composition, geometry, and method steps. A medtech startup’s FTO search typically targets:

• U.S. utility patents and published applications that are still in-force (or could issue).
• Design patents, if product appearance is a differentiator.
• Sometimes foreign patents, if manufacturing or market entry involves other jurisdictions.

The search uses classification codes—like CPC or USPC—and keywords tailored to the device’s technical domain. FDA product codes can narrow the search for similar devices, but they’re just a starting point. A formal FTO opinion is a legal document prepared by a patent attorney, not a database screenshot. It weighs claim scope, potential arguments for non-infringement, and even validity concerns.

One more point: a freedom-to-operate search is not a patentability search. A patentability search looks for prior art to predict whether your own application will be allowed. An FTO search looks for existing, enforceable rights that block your path.

When to Run an FTO Analysis in the MedTech Product Lifecycle

The best time for a full FTO analysis is after design freeze but before you sink money into tooling, regulatory submissions, or clinical trials. Run it too early and the device specifications will shift, making the opinion obsolete. Run it too late and you may discover a blocking patent after you’ve already committed to a design.

A typical sequence for a medtech startup:

1. Concept phase: run a broad patent landscape search to spot potential roadblocks and inform early design decisions.
2. Prototyping and iteration: update the landscape as the design evolves, but hold off on the formal FTO.
3. Design lock: commission the full freedom-to-operate analysis. The device configuration, materials, and intended use should be near-final.
4. Regulatory filing: incorporate FTO findings before choosing your FDA pathway—whether it’s a 510(k), De Novo, or PMA. A cleared device that must infringe a patent isn’t much better than an uncleared one. While you’re planning that pathway, you might also be mapping how to choose your FDA submission route.
5. Investor due diligence: serious investors almost always ask for an FTO opinion. Having one ready can accelerate the round and increase valuation.

What an FTO Analysis Costs (and Why it’s Worth It)

Costs vary by complexity, but a professional freedom-to-operate analysis for a medtech device typically falls between $15,000 and $50,000. A simple stand-alone catheter might come in at the lower end. A multi-component surgical robot or a system with software and hardware integration can push the bill higher.

That fee usually covers the search itself, claim charting, and a written opinion letter from a registered patent attorney. It takes weeks, not days. Superficial searches that rely only on Google Patents or free databases miss claims buried in broad language. They also won't hold up in due diligence or—worst case—in litigation.

For a medtech startup, $25,000 can feel like a lot. Compare it to the cost of defending a single patent infringement suit, which routinely exceeds $1 million before trial. Or the cost of a product redesign after regulatory clearance. The FTO analysis is an insurance policy.

Design-Around Strategies After an FTO Search

When the FTO search finds a patent that reads on your device, you have options:

1. Design around the claims. Change a feature or material so your product no longer meets a claim limitation. For example, a startup designing a wearable sensor finds a patent that covers a “flexible substrate layer with an adhesive attached to a battery.” By redesigning the sensor to use inductive power instead of an on-board battery, they avoid infringement entirely. This works only if you can make the change without sacrificing clinical performance or regulatory clearance.

2. License the patent. Negotiate a royalty-bearing license. This can be viable if the patent owner is willing and the royalty doesn’t kill margins.

3. Challenge validity. If the patent appears weak—bad prior art, poor claim drafting—you might file an inter partes review (IPR) or seek an opinion that the patent is invalid. This is a high-stakes move and not the first choice for most startups.

4. Proceed with a non-infringement opinion. If your attorney believes a reasonable argument exists that your device does not infringe under the correct claim construction, you can rely on a formal opinion of non-infringement. This doesn’t remove the risk, but it can mitigate willful infringement exposure and give investors comfort.

The design-around path is usually the cleanest. It’s why the FTO phase and the engineering phase should overlap. A savvy team lines up design alternatives before locking in manufacturing.

Actionable Takeaways

• A freedom-to-operate analysis is a defensive exercise. It doesn’t replace patentability searching; it answers a different question.
• Commission a formal FTO search once your device specs are stable—after design freeze, before regulatory submission.
• Budget $15,000–$50,000 for a professional opinion; it’s cheaper than litigation or a forced redesign.
• If a blocking patent appears, prioritize design-around strategies while the design is still fluid.
• Pair FTO with your medical device reimbursement strategy and FDA pathway choice to de-risk commercialization. Tools like Caduvo can help you map the regulatory and reimbursement landscape that shapes the product the FTO opinion must protect.